16630771

Source:http://linkedlifedata.com/resource/pubmed/id/16630771

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0034656, umls-concept:C0076275, umls-concept:C0087111, umls-concept:C0400966
pubmed:issue	5
pubmed:dateCreated	2006-5-8
pubmed:abstractText	Few controlled studies have addressed the issue of effective medical treatment for nonalcoholic fatty liver disease (NAFLD). We herein assessed the effect of orlistat in patients with NAFLD.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101160775
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Obesity Agents, http://linkedlifedata.com/resource/pubmed/chemical/Lactones, http://linkedlifedata.com/resource/pubmed/chemical/orlistat
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1542-3565
pubmed:author	pubmed-author:BlendisLaurenceL, pubmed-author:BrazowskyEliE, pubmed-author:HalpernZamirZ, pubmed-author:KesslerAdaA, pubmed-author:LeshnoMosheM, pubmed-author:LurieYoavY, pubmed-author:OrenRanR, pubmed-author:SantoMosheM, pubmed-author:WebbMurielM, pubmed-author:Zelber-SagiShiraS
pubmed:issnType	Print
pubmed:volume	4
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	639-44
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:16630771-Adolescent, pubmed-meshheading:16630771-Adult, pubmed-meshheading:16630771-Aged, pubmed-meshheading:16630771-Anti-Obesity Agents, pubmed-meshheading:16630771-Biopsy, Needle, pubmed-meshheading:16630771-Body Mass Index, pubmed-meshheading:16630771-Dose-Response Relationship, Drug, pubmed-meshheading:16630771-Double-Blind Method, pubmed-meshheading:16630771-Drug Administration Schedule, pubmed-meshheading:16630771-Fatty Liver, pubmed-meshheading:16630771-Female, pubmed-meshheading:16630771-Follow-Up Studies, pubmed-meshheading:16630771-Humans, pubmed-meshheading:16630771-Immunohistochemistry, pubmed-meshheading:16630771-Lactones, pubmed-meshheading:16630771-Liver Function Tests, pubmed-meshheading:16630771-Male, pubmed-meshheading:16630771-Middle Aged, pubmed-meshheading:16630771-Probability, pubmed-meshheading:16630771-Reference Values, pubmed-meshheading:16630771-Risk Assessment, pubmed-meshheading:16630771-Severity of Illness Index, pubmed-meshheading:16630771-Treatment Outcome, pubmed-meshheading:16630771-Ultrasonography, Doppler, pubmed-meshheading:16630771-Weight Loss
pubmed:year	2006
pubmed:articleTitle	A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease.
pubmed:affiliation	The Liver Unit, Department of Gastroenterology, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
pubmed:publicationType	Journal Article, Comparative Study, Randomized Controlled Trial